Auristone Providing actionable clinical insights with our epigenomics based workflows.
Auristone has raised $4.0M in total funding. The most recent round was Seed. The last funding was announced in April 2024.
Auristone's investors include Elev8.VC, Seeds Capital, Genedant.
Auristone is headquartered in Singapore, Singapore.
Auristone Providing actionable clinical insights with our epigenomics based workflows.
Auristone is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Auristone — Funding & Investors." VCBacked, April 2, 2024, https://www.vcbacked.co/company/auristone. Accessed September 16, 2026.
VCBacked. (2024). Auristone — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/auristone
{{cite web |title=Auristone — Funding & Investors |url=https://www.vcbacked.co/company/auristone |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated